Advertisement
Screener

Nantahala Capital Management, LLC Historic Quarter Change: Foreign Stocks, Reduced

Nantahala Capital Management, LLC historic quarter change: Foreign Stocks, Reduced

In share positions in stocks (depositary receipts and foreign shares traded over the counter), over 23 quarters from 2013-06-30 to 2026-06-30, Nantahala Capital Management, LLC opened 9 positions, added to 21, reduced 18 and sold out of 6.

  • Q2 2026: Stock SLN; Country of operation —; Class ADS; Shares before 2,146,731.
  • Q2 2026: Stock ABVX; Country of operation —; Class SPONSORED ADS; Shares before 137,237.
  • Q1 2026: Stock ABVX; Country of operation —; Class SPONSORED ADS; Shares before 153,235.
  • Q4 2025: Stock ABVX; Country of operation —; Class SPONSORED ADS; Shares before 557,564.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1472322), 23 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-14); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-13); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-15); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-15); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-16); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-16); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-13); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-08-14); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-17); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2011-12-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q2 2026SLN
SILENCE THERAPEUTICS PLC
ADS2,146,7311,346,731-800,000$11,313,272$14,787,106+$3,473,8342026-08-14
Q2 2026ABVX
ABIVAX SA
SPONSORED ADS137,237133,759-3,478$15,281,340$17,824,724+$2,543,3842026-08-14
Q1 2026ABVX
ABIVAX SA
SPONSORED ADS153,235137,237-15,998$20,664,506$15,281,340-$5,383,1662026-05-15
Q4 2025ABVX
ABIVAX SA
SPONSORED ADS557,564153,235-404,329$47,337,184$20,664,506-$26,672,6782026-02-13
Q4 2025CMPS
COMPASS PATHWAYS PLC
SPONSORED ADS1,729,930443,293-1,286,637$9,912,499$3,058,722-$6,853,7772026-02-13
Q4 2025CNTA
CENTESSA PHARMACEUTICALS PLC
SPONSORED ADS404,803254,803-150,000$9,816,473$6,372,623-$3,443,8502026-02-13
Q3 2025ABVX
ABIVAX SA
SPONSORED ADS1,482,994557,564-925,430$11,344,904$47,337,184+$35,992,2802025-11-14
Q3 2025CNTA
CENTESSA PHARMACEUTICALS PLC
SPONSORED ADS554,803404,803-150,000$7,290,111$9,816,473+$2,526,3622025-11-14
Q3 2025CMPS
COMPASS PATHWAYS PLC
SPONSORED ADS4,179,9301,729,930-2,450,000$11,703,804$9,912,499-$1,791,3052025-11-14
Q1 2025SLN
SILENCE THERAPEUTICS PLC
ADS1,049,6761,042,427-7,249$7,221,771$2,939,644-$4,282,1272025-05-15
Q1 2025GPCR
STRUCTURE THERAPEUTICS INC
United StatesSPONSORED ADS221,000168,553-52,447$5,993,520$2,917,652-$3,075,8682025-05-15
Q1 2025THTX
THERATECHNOLOGIES INC
COM NEW2,682,2282,422,563-259,665$4,854,833$3,476,378-$1,378,4552025-05-15
Q1 2025SGRP
SPAR GROUP INC
United StatesCOM662,028660,688-1,340$1,284,334$872,108-$412,2262025-05-15
Q2 2024ABVX
ABIVAX SA
SPONSORED ADS1,010,034985,634-24,400$14,443,486$13,030,081-$1,413,4052024-08-14
Q2 2024SGRP
SPAR GROUP INC
United StatesCOM879,189662,028-217,161$896,773$1,595,487+$698,7142024-08-14
Q3 2016LNWO
SCIENTIFIC GAMES CORP
United StatesCL A2,967,0022,067,876-899,126$27,267,000$23,305,000-$3,962,0002016-11-15
Q2 2016LNWO
SCIENTIFIC GAMES CORP
United StatesCL A3,585,9012,967,002-618,899$33,815,000$27,267,000-$6,548,0002016-08-15
Q3 2013LNWO
SCIENTIFIC GAMES CORP
United StatesCL A370,586163,815-206,771$4,169,000$2,649,000-$1,520,0002013-11-14

Similar Firms

Firm NameCountry13F ValueHoldings
TIMUCUAN ASSET MANAGEMENT INC/FLUnited States$2.717B28
Fidelity National Financial, Inc.United States$2.716B21
Arizona PSPRS TrustUnited States$2.718B10
Cornerstone Advisors, LLCUnited States$2.718B99
XN LPUnited States$2.722B23
NICOLET BANKSHARES INCUnited States$2.711B832
MIRAE ASSET SECURITIES (USA) INC.United States$2.723B153
PROFUND ADVISORS LLCUnited States$2.724B1,092
Bowie Capital Management, LLCUnited States$2.708B36
Shaolin Capital Management LLCUnited States$2.705B491